Reed, M., Cairns, D.A. orcid.org/0000-0002-2338-0179, Pawlyn, C. et al. (13 more authors) (2023) The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial. In: Blood. 65th ASH Annual Meeting and Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 3366-3368.
Metadata
Item Type: | Proceedings Paper |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2023 by The American Society of Hematology. Reproduced in accordance with the publisher's self-archiving policy. |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds) |
Funding Information: | Funder Grant number Cancer Research UK Supplier No: 138573 A25447 Celgene Corporation RV-MM-PI-0251 Merck Sharp & Dohme Ltd MERCK - MYELOMA XI |
Depositing User: | Symplectic Publications |
Date Deposited: | 11 Jun 2024 10:17 |
Last Modified: | 02 Nov 2024 01:13 |
Status: | Published |
Publisher: | American Society of Hematology |
Identification Number: | 10.1182/blood-2023-181939 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:213274 |